Curevo Inc
Advertisement
Curevo Inc is a clinical-stage biotech company based in Seattle, WA, dedicated to developing next-generation non-mRNA vaccines. They focus on addressing unmet medical needs by bringing effective and better-tolerated vaccines to market quickly and efficiently.
Their current program, amezosvatein, includes a non-mRNA, adjuvanted subunit vaccine for shingles (herpes zoster) and chickenpox (varicella). The Phase 2 trial results have shown promising efficacy and safety, with a non-inferior immune response and lower adverse events compared to existing vaccines. Curevo Inc aims to increase vaccination rates for shingles and address accessibility issues by developing vaccines that are easy to scale up for global demand.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2024. All rights reserved.
Advertisement


